Clinical Trial

Ma-Spore ALL 2020 Study

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary objective of this trial is to improve the overall survival rate of children and young adult with B-lineage acute lymphoblastic leukemia (B-ALL) in Singapore and Malaysia in the context of a multicenter cooperative trial using a risk-stratified therapy.
Trial Details
NCT Number NCT06336395
Lead Sponsor National University Hospital, Singapore
Conditions B Lymphoblastic Leukemia
Enrollment 500 participants
Start Date 2020-03-04
Primary Completion 2030-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2024-03-28